InvestorNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Initiates Clinical Trial for CBD-Based Therapeutic Candidate – CaniDermRx
Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”) based therapeutics and wellness products, today announced its initiation of an exploratory clinical study of CaniDermRx. Jupiter’s prescription topical cream candidate, CaniDermRx, combines CBD and aspartame as its active ingredients in the treatment of first degree burns. While, to Jupiter's knowledge, no double-blind, randomized controlled study has demonstrated efficacy of a CBD-aspartame product in the…